People’s Republic of China

Ying Li

Ying Li is a Professor at Peking Union Medical College Hospital (PUMCH), Director of the cornea and refractive surgery center of PUMCH, and Vice Director of cornea committee of Chinese Academy of Ophthalmology. Professor Li is a renowned corneal disease expert and refractive surgeon in China. She pioneered the refractive surgery, phakic intraocular lens implantation (ICL) for high myopia, and ACE presbyopia surgery in China. She was also among the first Chinese doctors to receive the international qualification for ICL implantation. During the past 30 years, with her extensive experience in refractive surgeries and managing difficult complications and other corneal diseases, Dr. Li has helped tens of thousands of patients. As the supervisor of the qualification tests for Excimer laser instrument in China, she has also made a tremendous contribution to the standardization of the refractive surgery in China. Professor Li is an active researcher of cornea diseases. She is currently in charge of national and municipal research projects that have been funded by ARVO and the Ministry of Education in China etc. Her research covers severe dry eye diseases, immune-related corneal inflammatory diseases, and the treatment of keratoconus. By 2016, she has authored nearly 100 publications and authored several books in Chinese. Her studies receive national recognition, including the Scientific Achievement Prize issued by China’s Ministry of Health. She also serves as the editor for six top-tier Chinese ophthalmic journals. In 2015, she ranked sixth on the list of the most influential Ophthalmologists in China.  Dr. Li is a member of the standing committee of the Ophthalmology subdivision of Chinese Microcirculation, Society Deputy Chief Member of corneal committee of Chinese Ophthalmologists, Association Member of Asian Dry Eye Society, Member of Academic Committee of China Dry Eye subdivision of Asian Dry Eye, Society Member of Ophthalmology subdivision of Association of Medical Exchanges across the Taiwan straits, and Member of Beijing Ophthalmology subdivision of Chinese Medical Association.
< back

20 April

TFOS Guidelines

Ocular surface disease (OSD)—including dry eye disease, blepharitis, meibomian gland dysfunction, conjunctival inflammation, and cicatrizing ocular surface disorders—is one of the most common and underrecognized factors affecting the success of eye surgery (e.g., refractive, cataract, glaucoma, strabismus, retina, and oculoplastic). Conversely, optimizing the ocular surface is one of the most effective, modifiable strategies for enhancing surgical success across all ophthalmic subspecialties. And the central clinical principle appears to be universal: elective eye surgery...

17 April

EssilorLuxottica Partners with TFOS to Advance Ocular Surface Health Worldwide

TFOS is pleased to announce a new strategic partnership with EssilorLuxottica, a global leader in vision care and eyewear. This collaboration will support shared efforts to elevate awareness, education, and scientific progress in tear film and ocular surface health worldwide. By combining TFOS’s expertise in evidence-based consensus and professional education with EssilorLuxottica’s global reach and innovation capabilities, the partnership aims to help improve standards of care for patients affected by dry eye disease and related ocular surface conditions. Together, TFOS and EssilorLuxottica...

10 February

Latin American TFOS Ambassador Meeting

TFOS has organized a special meeting of the Latin American TFOS Ambassadors. This meeting, which will occur in Panama City this May, has two goals: first, to address the unmet needs for the management (e.g. diagnosis & treatment) of ocular surface diseases in their country/region, as well as what the Ambassadors perceive as short and long term scientific/clinical solutions; and second, to create a report for publication in a peer-reviewed journal. Participants will include TFOS Ambassadors from Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Guatemala, Honduras,...

Corporate Advisory Board Members